Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C1762617 (weakness)
 37,932 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

The title compound, [Pd(C19H17NO4)I(C18H15P)], crystallizes with four independent molecules in the asymmetric unit. The main difference between the molecules is the disposition of the PPh3 ligand, for which in each molecule one ring is perpendicular to the ligand plane, but may be directed in either direction away from the plane; of the four molecules, two represent each possible direction. The independent molecules are arranged to form a chain parallel to [101] with an approximate translation of (a+c)/4 between successive molecules, excluding the PPh3 rings. This leads to a systematic weakness of the reflections with h + l not equal 4n.
 ...
PMID:An organometallic compound with Z' = 4: {2-[2-(benzylideneamino)phenyl]-1,2-bis(methoxycarbonyl)ethenyl-kappa2C1,N}iodo(triphenylphosphine-kappaP)palladium(II). 1720 36